METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism

The persistent airway inflammation is the main characteristic of chronic obstructive pulmonary disease (COPD), typically caused by an indoor environment pollution cigarette smoke (CS). METTL16 is an m6A methyltransferase that has been proven to be closely associated with the occurrence of various di...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyu Jia, Shan Liu, Chunan Sun, Manni Zhu, Qi Yuan, Min Wang, Tingting Xu, Zhengxia Wang, Zhongqi Chen, Mao Huang, Ningfei Ji, Mingshun Zhang
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Ecotoxicology and Environmental Safety
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S014765132401594X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590968219500544
author Xinyu Jia
Shan Liu
Chunan Sun
Manni Zhu
Qi Yuan
Min Wang
Tingting Xu
Zhengxia Wang
Zhongqi Chen
Mao Huang
Ningfei Ji
Mingshun Zhang
author_facet Xinyu Jia
Shan Liu
Chunan Sun
Manni Zhu
Qi Yuan
Min Wang
Tingting Xu
Zhengxia Wang
Zhongqi Chen
Mao Huang
Ningfei Ji
Mingshun Zhang
author_sort Xinyu Jia
collection DOAJ
description The persistent airway inflammation is the main characteristic of chronic obstructive pulmonary disease (COPD), typically caused by an indoor environment pollution cigarette smoke (CS). METTL16 is an m6A methyltransferase that has been proven to be closely associated with the occurrence of various diseases. However, its exact role in smoking-induced COPD remains to be investigated. In this study, we found that the level of METTL16 was aberrantly decreased in lung tissues of COPD smokers. Similarly, murine model induced by CS and lung epithelial cell model induced by cigarette smoke extract (CSE) also confirmed this discovery. Moreover, in the Mettl16-deficient (Mettl16+/-) mice challenged with CS, airway inflammation was aggravated. To identify the potential target genes and regulatory pathways through METTL16, methylated RNA immunoprecipitation sequencing (meRIP-seq), RNA sequencing (RNA-seq) and metabolomic profiling were used. Knockdown of METTL16 significantly reduced the stability of glutamic-oxaloacetic transaminase 2 (GOT2) and downregulated its expression through m6A modification, while reprogramed glutamine metabolism in lung epithelial cells. Significant reduction in inflammation levels was observed in the 3-month COPD murine model fed a glutamine-supplemented diet. Mechanistically, METTL16 could regulate lung epithelial mitochondrial function by participating in the reprogramming of glutamine metabolism. Our study characterized the role of the METTL16/GOT2/glutamine axis in the occurrence and development of COPD, and emphasized the potential value of METTL16 and glutamine in the therapy of chronic airway inflammation in smoking-induced COPD.
format Article
id doaj-art-8dff920b27d64683904cf48965783853
institution Kabale University
issn 0147-6513
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Ecotoxicology and Environmental Safety
spelling doaj-art-8dff920b27d64683904cf489657838532025-01-23T05:25:50ZengElsevierEcotoxicology and Environmental Safety0147-65132025-01-01289117518METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolismXinyu Jia0Shan Liu1Chunan Sun2Manni Zhu3Qi Yuan4Min Wang5Tingting Xu6Zhengxia Wang7Zhongqi Chen8Mao Huang9Ningfei Ji10Mingshun Zhang11Department of Respiratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaJiangsu Province Engineering Research Center of Antibody Drug, NHC Key Laboratory of Antibody Technique, Department of Immunology, Nanjing Medical University, Nanjing, ChinaJiangsu Province Engineering Research Center of Antibody Drug, NHC Key Laboratory of Antibody Technique, Department of Immunology, Nanjing Medical University, Nanjing, ChinaDepartment of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Corresponding authors.Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Corresponding authors.Jiangsu Province Engineering Research Center of Antibody Drug, NHC Key Laboratory of Antibody Technique, Department of Immunology, Nanjing Medical University, Nanjing, China; Corresponding authors.The persistent airway inflammation is the main characteristic of chronic obstructive pulmonary disease (COPD), typically caused by an indoor environment pollution cigarette smoke (CS). METTL16 is an m6A methyltransferase that has been proven to be closely associated with the occurrence of various diseases. However, its exact role in smoking-induced COPD remains to be investigated. In this study, we found that the level of METTL16 was aberrantly decreased in lung tissues of COPD smokers. Similarly, murine model induced by CS and lung epithelial cell model induced by cigarette smoke extract (CSE) also confirmed this discovery. Moreover, in the Mettl16-deficient (Mettl16+/-) mice challenged with CS, airway inflammation was aggravated. To identify the potential target genes and regulatory pathways through METTL16, methylated RNA immunoprecipitation sequencing (meRIP-seq), RNA sequencing (RNA-seq) and metabolomic profiling were used. Knockdown of METTL16 significantly reduced the stability of glutamic-oxaloacetic transaminase 2 (GOT2) and downregulated its expression through m6A modification, while reprogramed glutamine metabolism in lung epithelial cells. Significant reduction in inflammation levels was observed in the 3-month COPD murine model fed a glutamine-supplemented diet. Mechanistically, METTL16 could regulate lung epithelial mitochondrial function by participating in the reprogramming of glutamine metabolism. Our study characterized the role of the METTL16/GOT2/glutamine axis in the occurrence and development of COPD, and emphasized the potential value of METTL16 and glutamine in the therapy of chronic airway inflammation in smoking-induced COPD.http://www.sciencedirect.com/science/article/pii/S014765132401594XMETTL16GlutamineAirway inflammationsCOPDCigarette smoke
spellingShingle Xinyu Jia
Shan Liu
Chunan Sun
Manni Zhu
Qi Yuan
Min Wang
Tingting Xu
Zhengxia Wang
Zhongqi Chen
Mao Huang
Ningfei Ji
Mingshun Zhang
METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism
Ecotoxicology and Environmental Safety
METTL16
Glutamine
Airway inflammations
COPD
Cigarette smoke
title METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism
title_full METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism
title_fullStr METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism
title_full_unstemmed METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism
title_short METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism
title_sort mettl16 controls airway inflammations in smoking induced copd via regulating glutamine metabolism
topic METTL16
Glutamine
Airway inflammations
COPD
Cigarette smoke
url http://www.sciencedirect.com/science/article/pii/S014765132401594X
work_keys_str_mv AT xinyujia mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT shanliu mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT chunansun mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT mannizhu mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT qiyuan mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT minwang mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT tingtingxu mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT zhengxiawang mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT zhongqichen mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT maohuang mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT ningfeiji mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism
AT mingshunzhang mettl16controlsairwayinflammationsinsmokinginducedcopdviaregulatingglutaminemetabolism